Genexi accelerates the transition of cutting-edge biotech projects from research to the market. GEN token is qualified as a utility token. The token will be used as a medium of exchange within the ecosystem.
ICO Countries Not Allowed
The following countries are not allowed to participate in the crowdsale:
- USA
Featured Video
GENEXI Details
Trusted Volume 24H
Trusted Volume calculates volume only from reputable crypto exchanges without fake volumes, all of which are considered to list accurate trading volumes.
$2,007 NVT Ratio
The Network Value to Transactions (NVT) ratio calculates the dollar value of crypto transaction activity relative to the network value.
1,876.69 Team Location Switzerland
GENEXI Technical Details
Blockchain Ethereum (ERC20)
Pre-ICO Details
Status | Pre-Sale Ended
Pre-ICO Start Date May 15, 2018
Pre-ICO End Date May 31, 2018
Pre-ICO Conversion
1 GEN = 0.01 USD
Pre-ICO Bonus
20%
Project Details
Status | Crowdsale Ended
KYC Required
ICO Start Date Jun 1, 2018
ICO End Date Jul 31, 2018
Soft Cap 20,000,000 USD
Hard Cap 70,000,000 USD
Total Supply 12,000,000,000 GEN
Investor Supply 8.400,000,000 GEN
ICO Conversion
1 GEN = 0.01 USD
Bonus Structure
17% Round 1 01.06 – 14.06
9% Round 2 15.06 – 28.06
5% Round 3 29.06 – 12.07
2% Round 4 13.07 – 31.07
Supply Distribution
70% Public Distribution
10% Long-term Foundation Budget
15% Founders, Team
5% Advisors and Early Contributors
----------
*Unsold tokens will be burned.
GENEXI Team
Co-Founder, CEO
Co-Founder, COO
Managing Director
Head of Medical Research
Head of Finance
Head of Operations
Head of Strategy
Head of Business Development
Head of Research
Head of HR